Worse prognosis of KRAS c.35 G > A mutant metastatic colorectal cancer (MCRC) patients treated with intensive triplet chemotherapy plus bevacizumab (FIr-B/FOx)
Title:
Worse prognosis of KRAS c.35 G > A mutant metastatic colorectal cancer (MCRC) patients treated with intensive triplet chemotherapy plus bevacizumab (FIr-B/FOx)
Author:
Bruera, Gemma Cannita, Katia Di Giacomo, Daniela Lamy, Aude Frébourg, Thierry Sabourin, Jean Christophe Tosi, Mario Alesse, Edoardo Ficorella, Corrado Ricevuto, Enrico